EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neuroinflammatory and Motor Alterations in LRRK2 * G2019S Transgenic Mice Without Enhanced Vulnerability to Aging or Chronic MPTP ‐Induced Nigrostriatal Neurodegeneration

Roberto García-Swinburn iD, Laura Morón-Márquez iD, Carmen Conde-Naranjo iD, Ernesto García-Roldán iD, Isabel Espadas iD, Alfonso Rodríguez-Gil iD, Reposo Ramírez-Lorca iD, Javier Villadiego iD, Juan José Toledo-Aral iD

Journal of Neurochemistry · 2026

DOI: 10.1111/jnc.70547 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurochemistry, 2026. Verfasst von Roberto García-Swinburn und 8 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain. Hauptthemen laut MEDLINE: Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, Aging, Neuroinflammatory Diseases, Substantia Nigra. Die Arbeit nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Estatal de Investigación, Consejería de Economía, Conocimiento, Empresas y Universidad, Junta de Andalucía, Consejería de Salud y Familias, Junta de Andalucía.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

LRRK2 G2019S mutation is the most common genetic cause of Parkinson's disease (PD) producing clinical manifestations similar to sporadic PD patients, hinting at the relevance of this mutation in the pathophysiological mechanisms of the disease. However, its role potentiating nigrostriatal neurodegeneration, particularly in response to mitochondrial dysfunction, remains unclear. Here, using histological, neurochemical and behavioral analyzes, we provide a complete characterization of a mouse model expressing the human LRRK2 G2019S mutation (hLRRK2*G2019S mice), in the context of aging and toxin‐induced parkinsonism. hLRRK2*G2019S young adult mice showed significant microglial activation and deficits in motor coordination, whereas aged transgenic displayed a hyperactive phenotype, despite the absence of evidence for nigrostriatal neurodegeneration in either young adult or aged animals. Furthermore, we assessed the vulnerability of LRRK2*G2019S transgenic mice to the chronic exposure to the mitochondrial complex I inhibitor 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP). Notably, no exacerbation of nigrostriatal neurodegeneration was observed in hLRRK2*G2019S mice, suggesting that this mutation does not increase sensitivity to mitochondrial stress. However, hLRRK2*G2019S MPTP‐treated mice present alterations, relative to WT counterparts, in the glial response induced by the neurotoxic treatment. These findings suggest that the G2019S mutation modulates the neuroimmune response but does not exacerbate nigrostriatal neurodegeneration in response to mitochondrial dysfunction. This highlights the mutation's complex role in PD pathophysiology. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leucine-Rich Repeat Serine-Threonine Protein Kinase-2AgingNeuroinflammatory DiseasesSubstantia NigraCorpus StriatumMPTP PoisoningParkinsonian DisordersMotor ActivityAnimalsMice, TransgenicMiceHumansMaleMice, Inbred C57BLMutation

Stichwörter der Autor:innen

LRRK2MPTPParkinson's diseaseagingneurodegeneration

Substanzen

Leucine-Rich Repeat Serine-Threonine Protein Kinase-2LRRK2 protein, human

Autor:innen und Institutionen

  • Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Sevilla, Spain.
  • Departamento de Fisiología Médica y Biofísica, Facultad de Medicina, Universidad de Sevilla, Sevilla, Spain.
  • Servicio de Neurología y Neurofisiología Clínica, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
  • Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.

ORCID-Profile: Roberto García-Swinburn, Laura Morón-Márquez, Carmen Conde-Naranjo, Ernesto García-Roldán, Isabel Espadas, Alfonso Rodríguez-Gil, Reposo Ramírez-Lorca, Javier Villadiego, Juan José Toledo-Aral

Förderung

  • Agencia Estatal de Investigación
  • Consejería de Economía, Conocimiento, Empresas y Universidad, Junta de Andalucía
  • Consejería de Salud y Familias, Junta de Andalucía

Zitieren

APA

García-Swinburn, R., Morón-Márquez, L., Conde-Naranjo, C., García-Roldán, E., Espadas, I., Rodríguez-Gil, A., Ramírez-Lorca, R., Villadiego, J., & Toledo-Aral, J. J. (2026). Neuroinflammatory and Motor Alterations in LRRK2 * G2019S Transgenic Mice Without Enhanced Vulnerability to Aging or Chronic MPTP ‐Induced Nigrostriatal Neurodegeneration. Journal of Neurochemistry. https://doi.org/10.1111/jnc.70547

Vancouver

García-Swinburn R, Morón-Márquez L, Conde-Naranjo C, García-Roldán E, Espadas I, Rodríguez-Gil A, et al. Neuroinflammatory and Motor Alterations in LRRK2 * G2019S Transgenic Mice Without Enhanced Vulnerability to Aging or Chronic MPTP ‐Induced Nigrostriatal Neurodegeneration. Journal of Neurochemistry. 2026. doi:10.1111/jnc.70547

BibTeX
@article{GarcaSwinburn2026,
  author = {García-Swinburn, Roberto and Morón-Márquez, Laura and Conde-Naranjo, Carmen and García-Roldán, Ernesto and Espadas, Isabel and Rodríguez-Gil, Alfonso and Ramírez-Lorca, Reposo and Villadiego, Javier and Toledo-Aral, Juan José},
  title = {Neuroinflammatory and Motor Alterations in LRRK2 * G2019S Transgenic Mice Without Enhanced Vulnerability to Aging or Chronic MPTP ‐Induced Nigrostriatal Neurodegeneration},
  journal = {Journal of Neurochemistry},
  year = {2026},
  doi = {10.1111/jnc.70547}
}
Kostenlos starten →